SIPAVIBART

UNII:	977D2P9YYW
Formula:
Preferred Substance Name:	SIPAVIBART

2768288-97-5
AZD3152
AZD-3152
GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-455) (VH (HOMO SAPIENS IGHV3-9*01 (94.9%) -(IGHD) -IGHJ1*01 (90.9%) L123>T (120), CDR-IMGT (8.8.18) (26-33.51-58.97-114)) (1-125) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 CH1 R120, CH3 E12, M14, IGHG1V39 CH2 F1.3, E1.2, S116, IGHG1V21 CH2 Y15.1, T16, E18 (CH1 R120 (222) (126-223), HINGE 1-15 (224-238), CH2 L1.3>F (242), L1.2>E (243), M15.1>Y (260), S16>T (262), T18>E (264), P116>S (339) (239-348), CH3 E12 (364), M14 (366) (349-453), CHS (454-455)) (126-455)), (228-214')-DISULFIDE WITH LAMBDA LIGHT CHAIN HOMO SAPIENS (1'-215') (V- LAMBDA (HOMO SAPIENS IGLV2-8*04 (94.8%) -IGLJ2*01 (100%), CDR-IMGT (9.3.9) (26-34.52-54.91-99)) (1'-109') -HOMO SAPIENS IGLC2*01 (100%) (110'-215')); DIMER (234-234'':237-237'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, DERIVED FROM THE CELL LINE CHO-K1, GLYCOFORM ALFA
IMMUNOGLOBULIN G1 (242-PHENYLALANINE,243-GLUTAMIC ACID,260-TYROSINE,262-THREONINE,264-GLUTAMIC ACID,339-SERINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL AZD3152 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AZD3152 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HOMO SAPIENS SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) PROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBODY
RQ043
SIPAVIBART [INN]
SIPAVIBART [USAN]
SIPAVIBART [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SIPAVIBART

Synonyms and Mappings

Resources